Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-09-20
1991-06-25
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Lymphokine
424 88, 424 91, 424 8591, 530389, 530390, 530391, 514826, 514829, 514890, A61K 39395, A61K 3935
Patent
active
050265458
ABSTRACT:
A pharmaceutical composition comprises an immune complex of an allergen and a purified antibody specific thereto, the allergen being selected from a specific subclass of antigen which causes immediate hypersensitivity that is mediated by IgE antibody, and a pharmacologically acceptable carrier or diluent. The method of using the compositions in the treatment of immediate hypersensitivity to the allergen is also described.
REFERENCES:
patent: 4140679 (1979-02-01), Malley
patent: 4234569 (1980-11-01), Marsh
patent: 4344938 (1982-08-01), Sedlacek et al.
patent: 4545986 (1985-10-01), Malley
patent: 4564600 (1986-01-01), Ali et al.
patent: 4714759 (1987-12-01), Whitaker
Fox, Nature, 314, 1985, pp. 132-133.
Gene Cloning; 1984, ed Glover, pp. 102-104.
Principles of Gene Manipulation, 1981, ed. Old et al, pp. 104-105, 119-120.
"Immunoregulation by Antigen/Antibody Complexes", Michael J. Caulfield et al., pp. 3680-3683, The Journal of Immunology, vol. 138, No. 11, Jun. 1, 1987.
"The Antibody Response to Specific Immune Complexes is Under Genetic Control and Correlates with the Expression of a Recurrent Idiotype", Michael J. Caulfield et al., pp. 75-86, J. Exp. Med., vol. 163, Jan. 1986.
"Idiotype-Restricted Antibody Response to Specific Immune Complexes", Michael J. Caulfield, pp. 451-457, Cellular Immunology 90, 1985.
"Suppression of Reaginic Antibody Formation", Weng Y. Lee, et al., pp. 829-836, The Journal of Immunology, vol. 114, No. 2, Feb. 1975.
"Suppression of Reaging Antibody Formation", Weng Y. Lee, et al., pp. 837-842, The Journal of Immunology, vol. 114, No. 2, part 2, Feb. 1975.
"Tolerization of B.sub.6 Cells by Conjugates of Haptens and Isologous-Globulins", Weng Y. Lee, et al., pp. 385-397, Cellular Immunology 58, 1981.
"Suppression of the IgE Antibody Response to Ovalbumin in Mice with a Conjugate of Ovalbumin and Isologus-Globulins", L. G. Filion, et al., pp. 115-128, Cellular Immunology 54, 1980.
"Suppression of Reaginic Antibody Formation", Weng Y. Lee, et al., pp. 927-934, The Journal of Immunology, vol. 117, No. 3, Sep. 1976.
"Experimental Myasthenia Gravis Inhibited by Receptor-Antireceptor Complexes", T. Barkas, et al., pp. 223-227, J. Clin. Lab. Immunol., 1982.
"Regulatory Effect of Antibody on the Immune Response", Jonathan W. Uhr, et al., pp. 80-126.
Sanders, "Allergy-A Protective Mechanism Out of Control", 48 C & EN 84-135 (May 1970).
Arend, "In Vitro Adherence of Soluble Immune Complexes to Macrophages", 136 J. Exp. Med. 514 (1972).
Geczy et al, "Suppression of Reaginic Antibody Formation in Guinea Pigs by Anti-Idiotypic Antibodies", 62 J. All. Clin. Immun. 261 (1978).
Klaus, "Antigen-Antibody Complexes Elicit Anti-Idiotypic Antibodies to Self Idiotopes", 272 Nature 265 (1978).
Klaus, "Generation of Memory Cells. III. Antibody Class Requirements for the Generation of B-Memory Cells by . . . ", 37 Immunology 345 (1979).
Klaus, "Cooperation Between Antigen-Reactive T Cells and Anti-Idiotypic B Cells in the Anti-Idiotypic Response . . . ", 278 Nature 354 (Mar. 22, 1979).
Blaser et al, "Suppression of Phosphorylcholine-Specific IgE Antibody Formation in BALB/c Mice . . . ", 9 Eur. J. Immunol. 1017 (1979).
Blaser et al, "Suppression of the Benzylpenicilloyl-(BPO) Specific IgE Formation with Isologous Anti-Idiotypic . . . ", 125 J. Immun. 24 (1980).
Blaser et al, "Investigation of a Syngeneic Murine Model for the Study of IgE Antibody Regulation with . . . ", 64 Inf. Archs Allergy 42 (1981).
Geha, "Current Concepts in Immunology-Regulation of Immune Response by Idiotypic-Antiidiotypic Interactions", 305 New England J. Med. 25 (1981).
"Primer on Allergic and Immunologic Diseases", 248 JAMA 2583, Nov. 26, 1982.
Blaser et al, "Regulation of the IgE Antibody Response by Idiotype-Anti-Idiotype Network", 32 Prog. Allergy 203 (1982).
Farkas, "Immunogenicity of Antigen Complexed with Antibody . . . ", 45 Immuno 483 (1982).
Geha et al, "The Regulation of Immunoglobulin E Antibody Synthesis in Man by Anti-Idiotypic Antibodies", 71 J. Clin. Invest. 46 (Jan. 1983).
Caulfield et al, "Induction of Idiotype-Specific Suppression T Cells with Antigen/Antibody Complexes", 157 J. Exp. Med. 1713 (1983).
Blaser et al, "Immune Networks in Immediate Type Allergic Diseases", 418 Ann. NY Acad. Sci. 330 (1983).
Blaser et al, "Regulatory Effects of Isologous Anti-Idiotypic Antibodies on the Formation of . . . ", 14 Eur. J. Immunol. 93-98 (1984).
Buisseret, "Allergy" Scientific American 82-91 (Aug. 1982).
50 Fed. Reg. 3082 (Jan. 23, 1985).
Lebeque Serge
Lebrun Philippe
Masson Pierre L.
Saint-Remy Jean-Marie
Baxter International Inc.
Draper Garnette D.
International Institute of Cellular and Molecular Pathology
LandOfFree
Treatment of allergy and composition therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of allergy and composition therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of allergy and composition therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1038802